CATX Stock Analysis: Buy, Sell, or Hold?
CATX - Perspective Therapeutics, Inc.
$4.71
0.08 (1.73%)
▲
5d:
+24.27%
30d:
+64.11%
90d:
+102.15%
WAIT
LOW Confidence
Analysis Updated: Feb 6, 2026 12:00 AM ET
Earnings: Mar 25, 2026
Get Alerted When CATX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
5 traders called CATX this week
83% bullish • 1 bearish
83% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CATX is 15.4% above fair value ($4.08). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CATX is 15.4% above fair value ($4.08). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CATX is currently trading at $4.71, which is considered extended relative to its 30-day fair value range of $2.24 to $4.08.
Technical Outlook: Technically, CATX is showing sideways momentum. Immediate support is located at $2.55, while resistance sits at $6.16.
Market Sentiment: CATX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+176.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CATX is showing sideways momentum. Immediate support is located at $2.55, while resistance sits at $6.16.
Market Sentiment: CATX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+176.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$2.24 -
$4.08
Company Quality Score
56/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+15.4% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: Trading 176.0% below Wall St target ($13.00)
- WARNING: Recommendation downgraded due to 15.4% overvaluation
Fair Price Analysis
30-Day Fair Range
$2.24 -
$4.08
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$2.55
Resistance Level
$6.16
Current Trend
Sideways
Technical data as of
Feb 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.49
Wall Street Target
$13.00
(+176.0%)
Revenue Growth (YoY)
-43.4%
Share & Embed Analysis
Last updated: February 08, 2026 11:19 PM ET
Data refreshes hourly during market hours. Next update: 12:19 AM
Data refreshes hourly during market hours. Next update: 12:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CATX showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$107 | 47 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 60 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 68 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
